Specialized Healthcare & Pharmaceutical Legal Advisory

We advised MedGenome, a leading genomic diagnostics company, on its Series E fundraise of approximately USD 47.5 million. This transaction supports the company's mission to broaden access to affordable, genetics-based diagnostics across emerging markets.

We advised health-tech startup Zeno Health on its $25 million Series C funding round led by STIC Investments. This transaction demonstrates our ability to guide growth-stage companies in securing capital for market expansion and technological enhancement.

We advised Infinx on its strategic acquisition of i3 Verticals' Healthcare Revenue Cycle Management (RCM) business for approximately USD 96 million. This deal expanded our client's footprint in the US healthcare market, particularly with academic medical centers.

Our team advised Infinx on its acquisition of Glidian, Inc. through a reverse triangular merger. This complex, cross-border transaction strengthened our client's patient access solutions and expanded their presence in the laboratory and healthcare technology market.

We advised Infinx on the acquisition of the assets and operations of Medreceivables Advisor, LLC (MRA). This deal strengthened our client's capabilities in specialized pathology coding and billing, expanding their service offerings in the US healthcare revenue cycle management space.

We guided Zeno Health, a health-tech pharmacy platform, on its acquisition of Tablt Pharmacy's assets on a slump sale basis. This transaction was structured to expand Zeno Health's last-mile medicine supply services into underserved markets across Eastern India.

We advised Ind-Swift Laboratories and its promoters on the INR 1,650 crore sale of its API and CRAMS businesses to IndiaRF. The complex deal involved advising on the business sale and a subsequent investment by our client into the acquiring entity.